Abstract

RESTREPO-MARTINEZ, Miguel et al. Autoimmune psychosis. Rev. alerg. Méx. [online]. 2021, vol.68, n.4, pp.276-290.  Epub Apr 08, 2022. ISSN 2448-9190.  https://doi.org/10.29262/ram.v68i4.981.

With the advent of the description of autoimmune encephalitis by different neuronal cell-surface antibodies (anti-NMDAr, among others) and that psychosis may be the only manifestation without neurological symptoms (epilepsy, movement disorders, autonomic dysfunction, altered state of consciousness) in 6.5 % of patients, the term “autoimmune psychosis” has become remarkably interesting among researchers. In 2020, an international consensus for the description and diagnostic approach of autoimmune psychosis was created. Through this consensus, by taking different criteria into account, the definition of autoimmune psychosis was proposed at different degrees of certainty (possible, probable, and defined). The purpose of these criteria is to underpin the autoimmune origin in patients who present psychosis with atypical characteristics, thus justifying the realization of laboratory studies and complementary clinical tests (lumbar puncture, electroencephalogram, and magnetic resonance imaging of the brain); in addition, these criteria are applied in patients with psychosis without neurological symptoms that do not fully meet the criteria of autoimmune encephalitis. As in autoimmune encephalitis, the early initiation of immunotherapy has a direct impact on the functional prognosis of patients, so an early initiation of treatment must be considered in clinical scenarios of probable or definite autoimmune psychosis.

Keywords : Autoimmune psychosis; Neurological symptoms; Autoimmune encephalitis.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )